Lykke Vestergaard Kastbjerg, 42, and her father Niels, 73, are among hundreds travelling to the UK for treatment.
Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today provided business ...
Initiation of confirmatory Phase 3 trial with roluperidone for negative symptoms of schizophrenia is planned for Q2 2026, with topline data anticipated in 2H 2027BURLINGTON, Mass., March 11, 2026 (GLO ...
Q4 2025 Earnings Call March 6, 2026 10:00 AM ESTCompany ParticipantsPatrick Giles Dear - PrincipalPaul Gannon - ...
Achieved Q4 2025 PEMGARDA® (pemivibart) net product revenue of $17.2 million, representing 25% growth year-over-year and 31% growth ...
TD Cowen 46th Annual Health Care Conference March 4, 2026 9:50 AM ESTCompany ParticipantsAlexander Schuth - Co-Founder, ...
The brand new position online game could have been motivated because of the famous Marvel comical character’s exploits, and you may utile link comes with five reels and you can 20 paylines. Yes, the ...
An already-approved IV drug significantly reduces the symptoms of lupus, a new clinical trial showed. More than three-quarters of lupus patients taking obinutuzumab (Gazvya) had a significant ...
Researchers at Washington University have developed a gut-specific drug that protects the liver and improves nutrient ...
With one day left of the main legislative session, Republican Gov. Larry Rhoden has signed 147 bills into law. The bills cover a wide range of topics from crypto ...
Understand the impact of IND delays on biotechnology companies and how they affect early-stage development and funding.
As NAD+ injections and IV drips trend from TikTok to the Kardashians, the science of longevity remains a work in progress. Explore the benefits, side effects, and the debate between oral precursors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results